Genocea Biosciences (NASDAQ: GNCA) is trading down 8% after-hours after the company announced that it intends to offer and sell ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE